SDI Stock

SDI FCF Conversion

Delisted·Jul 7, 2026

The FCF Conversion Rate (FCF/EBITDA) of SDI (SDI.AX) as of Sep 13, 2026 is 84.71 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 38.67 % — a change of 119.05% (higher).

FCF Conversion

84.71 %

YoY

119.05%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of SDI is 2026 84.71 % . FCF Conversion Rate (FCF/EBITDA) of SDI was 2025 38.67 % . It decreases by 119.05% higher compared to the previous year.

The SDI FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
125.77 AUD
Jan 1, 2019
63.46 AUD
Jan 1, 2020
54.73 AUD
Jan 1, 2021
96.60 AUD
Jan 1, 2022
-0.84 AUD
Jan 1, 2023
-303.61 AUD
Jan 1, 2024
38.67 AUD
Jan 1, 2025
84.71 AUD
The SDI FCF Conversion history
YEARFCF ConversionYoY
84.71 %+119.05%
38.67 %-112.74%
-303.61 %+36,139.56%
-0.84 %-100.87%
96.60 %+76.50%
54.73 %-13.75%
63.46 %-49.54%
125.77 %+85.83%
67.68 %+19.84%
56.48 %+16.68%
48.40 %+21.38%
39.88 %—
Access this data via the Eulerpool API
Get Free API Key

SDI Stock analysis

What does SDI do? SDI Ltd is a British company specializing in the development and manufacture of scientific and medical devices. The company was founded by John Poulter in 1952 and is headquartered in Basingstoke, Hampshire. The history of SDI Ltd began with the development of scientific measuring devices, particularly instruments for measuring optical signals. Over the years, the company has specialized in the development of devices for medical diagnostics and therapy. SDI Ltd now operates in various areas. One of its main business fields is microbiology and infection prevention. The company offers a wide range of products including test systems for infectious diseases such as HIV, Hepatitis B and C, tuberculosis, and malaria. Another business field of SDI Ltd is the development of devices for the diagnosis of cancer and other diseases. The company offers both instruments for tissue sampling as well as automated diagnostic systems. SDI Ltd is also active in medical technology and offers a wide range of products, from simple instruments like thermal thermometers to complex surgical instruments and implants. In addition to medical diagnostics and therapy, SDI Ltd is also active in the field of analytical technology. The company offers instruments for chemical analysis, environmental monitoring, and food sampling. The business model of SDI Ltd is based on the development and manufacture of high-quality and reliable devices for scientific, medical, and industrial use. The company relies on close collaboration with customers and partners to provide innovative solutions for the challenges of modern science and medicine. An important part of SDI Ltd's business model is research and development. The company invests a significant portion of its revenue in the development of new products and technologies to always offer its customers the latest and best solutions. Overall, SDI Ltd has established itself as a leading company in the field of scientific and medical devices. The company has a long history of successful product developments and is known for its high quality, reliability, and innovation. With its wide range of products and its commitment to research and development, SDI Ltd is well-equipped to continue playing an important role in science and medicine in the future. SDI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SDI stock

FCF Conversion Rate (FCF/EBITDA) of SDI is 84.71 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of SDI changed from 38.67 % to 84.71 %, representing a 119.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) SDI since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s SDI with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — SDI

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — SDI